Background: Bariatric surgery has been shown to improve cardiovascular risk factors but long term benefit for survival and cardiovascular events are still uncertain.
Introduction
Obesity is a worldwide problem with significant consequences on individuals and society. The global age-standardized prevalence of obesity has nearly doubled from 6 .4% in 1980 to 12% in 2008. [1] Obesity is associated with cardiovascular disease, type 2 diabetes, several cancers, diminished average life expectancy, [2] and significant impairments in quality of life. [3] In addition, overweight or obesity in young adulthood and middle age has long-term adverse consequences for health care costs in older age. [4] While people may reduce their weight by dieting, physical activity, behavioral modification or consumption of drugs such as orlistat, many people find it difficult to consistently maintain any reduction in weight. [5] Bariatric surgery is an option that has been shown to be associated with significant weight reduction compared to non-surgical control groups, and potentially confers improvements in disease conditions associated with obesity. [6] The effect of bariatric surgery on a number of endpoints has been extensively studied in the literature. Pontirroli et al conducted a systematic review and meta-analysis of 8 studies with 44,022 participants and found that compared to controls, surgery was associated with a reduced mortality (OR 0.55 95% CI 0.49-0.63). [7] Another metaanalysis has shown that bariatric surgery has significant benefits on cardiovascular risk factors including hypertension, diabetes and hyperlipidemia. [8] In addition, there is evidence to suggest that it results in resolution of major comorbidities including metabolic syndrome, non-alcoholic fatty liver disease, nephropathy, left ventricular hypertrophy and obstructive sleep apnea. [9] However, there has yet to be a systematic review which evaluates the impact of bariatric surgery on cardiovascular events.
In this study, we performed a systematic review and meta-analysis to evaluate the impact of bariatric surgery on long-term incident cardiovascular disease and mortality.
Methods

Eligibility criteria
We selected randomized trials and controlled observational studies (case-control or cohort design) that evaluated the association of bariatric surgery and clinical outcomes. The following criteria were used for inclusion:
1. sample size of >100 participants undergoing bariatric surgery.
2. control group consisting of participants with non-surgical management, either in the same healthcare setting or as community-based controls.
3. aimed to evaluate one of the following outcomes: myocardial infarction/ischemic heart disease/coronary heart disease, stroke or mortality.
There was no restriction on whether the study has to be prospective or retrospective nor were there any restriction on the type of bariatric surgery.
Search strategy
We searched MEDLINE and EMBASE from inception up to August 2013 (NHS Evidence) with no language limitations using the broad free-text and indexing search
terms [(bariatric surgery) AND ((acute coronary syndrome) OR (ischemic heart disease) OR (ischaemic heart disease) OR (coronary heart disease) OR (stroke) OR (cerebrovascular accident) OR (mortality) OR (cardiovascular disease))]
(Supplementary Data 1). In addition, we signed up with PubMed to receive automated electronic notifications for any new articles containing the 'bariatric surgery'. Bibliographies of included studies and recent review articles were checked for additional relevant studies.
Study selection and data extraction
Two reviewers (CSK and AP) evaluated all titles and abstracts for studies that met the inclusion criteria, and excluded any articles that clearly did not meet the selection criteria. The potential inclusions were checked by one author (YKL). Full reports (where available) of potentially relevant studies were retrieved and independently checked for eligibility. Data from the included studies were then extracted by one of three reviewers (CSK or AP or MAK) who collected information on study design, drug exposure, study location, characteristics of participants onto a pre-formatted spreadsheet. The data table was then checked (in an unblinded manner) by at least one other reviewer (MAM or YKL). For the outcomes data, CSK and YKL independently extracted odds ratios (unadjusted or adjusted) where available; otherwise raw numbers were recorded to enable calculation of unadjusted odds ratios. If a study had two or more groups of control participants, we pooled the data together to create a single comparator arm.
Any uncertainties or discrepancies were resolved through re-checking against the source papers, and through discussion with another reviewer. Also, we contacted authors if there were any areas that required clarification.
Assessment of risk of bias
We developed our risk of bias assessment considering the recommendations of the Cochrane Adverse Effects Methods Group. Here, our risk of bias assessment included the selection of treatment group (bariatric surgery) and control group (no bariatric surgery), the ascertainment of clinical outcome, the extent of loss to follow up, the use of propensity matching or adjustment for confounders and the generalizability of the study. [10] Generalizability was assessed by considering whether the treatment group and control group were representative of the obese patients treated with surgery and obese patients living in the community, respectively. We aimed to generate funnel plots to assess the possibility of publication bias, provided that there were >10 studies available in the meta-analysis, with no evidence of substantial statistical heterogeneity. [11] 
Data analysis
We used RevMan 5.2. (Nordic Cochrane Centre) to conduct random effects metaanalysis using inverse variance method for pooled odds ratios (OR). We assumed similarity between the risk ratio and odds ratio because the incidence of adverse outcomes was low. [12] We evaluated both adjusted and unadjusted data from primary studies, although we preferentially used adjusted data where available.
Statistical heterogeneity was assessed using I 2 statistic, [13] with I 2 values of 30-60%
representing a moderate level of heterogeneity. Pre-specified sensitivity analysis was performed by evaluating the effect of using adjusted as opposed to crude estimates, and with exclusion of studies at moderate-high risk of bias. We also aimed to consider non-diabetic and diabetic cohorts separately.
Results
Our search yielded 2764 potentially relevant articles and after removal of duplicates there were 2295 titles and abstracts, which were screened. There were 30 potentially relevant articles and the full text of these articles was retrieved and 14 studies met the inclusion criteria after full text review. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] The process of study selection is shown in Figure 1 .
The available study designs consisted of three prospective cohorts [15, 20, 26, 27 The quality assessment of the included studies is shown in Table 2 . Some extent of lost to follow up was present in four studies [15, 17, 25, 28] , with the greatest loss seen in Sowemimo 2007 (>10% of cohort with missing data) [28] . Four studies presented unadjusted results for some of the outcomes. [15, 18, 20, 21] Overall, four studies were considered to be of moderate-high risk of bias due to lack of adjustment for confounders or substantial loss to follow-up , [15, 18, 20, 28] while the others were at moderate or lower risk of bias.
The types of bariatric surgery and control groups, their follow up and outcome events or risk estimates are shown in Table 3 . Three studies did not specifically specify the type of bariatric surgery performed. [16, 21, 22] Two studies only included obese participants with type 2 diabetes [16, 21] and one study used orthopedic and gastrointestinal surgical patients as control groups. [25] The follow up of the included studies ranged from up to 2 years to over 14.7 years. All include studies reported mortality outcome, and four studies evaluated myocardial infarction and stroke events, as well as a cardiovascular composite which typically consisted of mortality, myocardial infarction and stroke. [14, 21, [25] [26] [27] 
Mortality outcomes
The analysis of risk of mortality with and without bariatric surgery is shown in Figure   2 . The absolute event rates for each study for relevant outcomes are reported in Supplementary randomized trials with 796 participants, and found that bariatric surgery was associated with significant reductions in weight, plasma triglyceride levels, plasma LDL cholesterol levels, HbA1c levels and increases in plasma HDL levels and rates of remission of diabetes but no significant difference in plasma cholesterol. [29] Another systematic review evaluated the effect of bariatric surgery on 73 different cardiovascular risk factors in 18 studies with 19543 participants. [8] The key findings of this meta-analysis was that bariatric surgery was associated with reduction of weight, hypertension, diabetes, hyperlipidaemia and significant improvements in echocardiographic parameters. Similar findings were found in a recent meta-analysis and meta-regression which found that bariatric surgery has early beneficial impacts on type 2 diabetes, hypertension and hyperlipidaemia. [30] While these systematic reviews consistently show that bariatric surgery is associated with significant improvements in cardioprotective risk factors none of them reported the effect on future cardiovascular event.
The effects of bariatric surgery at physiological and cellular levels has been previously reviewed. [31] It directly reduces the number of adipocytes which leads to decreased levels of leptin and resistin [32, 33] and studies suggest that these hormones may have a role in atherogenesis [34, 35] . In addition, surgery impacts the endothelium directly causing decreases in E-selectin, P-selectin and ICAM-1 [36] [37] [38] which are believed to be the markers that reflect the level of established cardiovascular risk [39] . The intervention also appears to reduce systemic inflammation and oxidative stress which are important processes in atherosclerosis; reduction in the levels of C-reactive protein, siallic acid, PAI-1, malondialdehyde and von Willebrand factor levels have been previously reported. [36, 40] In addition, bariatric surgery also has positive effects on other factors which increase cardiovascular risk such as athersclerotic load, insulin sensitivity and left ventricular function. [31] Furthermore, post surgery weight reduction may improve physical activity, image and motivation to maintain healthier lifestyles.
In terms of absolute event rates, we found that there were lower fraction of events in the bariatric surgery group compared to non-operated overweight control groups for all outcomes. However, the mortality rate is still much higher than that of the general population aged 15 to 60 in America (0.5%) and England (0.4%) (WHO). We are also able to estimate, based on the mortality rate in a community cohort of severely obese patients, [14] Our study has several strengths. We were able to include a total sample size of nearly 200,000 (29,208 cases of bariatric surgery and 166,200 nonsurgical controls) with a follow up period that ranged from 2 years to 14.7 years which allowed capture of a enough cardiovascular events. In addition, our analysis allowed for evaluation of the risk of myocardial infarction, stroke, cardiovascular events and mortality. We were also able to consider the effects of adjustment and study quality in our analyses.
Study limitations
Our study has several limitations. All the included studies were observational in nature as the randomized controlled trial of bariatric surgery did not capture sufficient cardiovascular events. Furthermore, there is high level of heterogeneity as there were different methods that were used to identify non-surgical controls. It is possible that in the absence of randomization patients may be selectively chosen for bariatric surgery because they are more likely to have positive outcomes after surgery. While some of the included studies did adjust for potential confounders it is possible that there are some unmeasured confounders which could not be fully accounted for.
Moreover, the quality of the studies varied, and only three studies were considered to be of low to moderate risk of bias. Nevertheless, the mortality and cardiovascular benefits associated with bariatric surgery remained significant even after we excluded moderate-high risk studies from all the meta-analyses. 
Future studies
Conclusions
In conclusion, current observational studies provide consistent evidence that morbidly obese patients undergoing bariatric surgery have lower rates of myocardial infarction, stroke, cardiovascular events and mortality compared to matched non surgical controls (mortality 3.6% vs. 11.4%, cardiovascular events 2.4% vs. 4.0%, myocardial infarction 1.3% vs. 2.5% and stroke 0.8% vs. 1.5%). Whilst, our data does not infer a causal relationship, our analysis suggests that bariatric surgery may be beneficial particularly in morbidly obese patients at risk of future cardiovascular events.
Whether or not these reductions in clinical events are also observed in prospective randomized studies should be evaluated. 
